Align Technology Inc

Align Technology maintains a conservative capital structure characterized by zero debt relative to equity, resulting in a debt-to-equity ratio of 0.0. The balance sheet holds $1.09 billion in cash and equivalents against total liabilities of $2.18 billion, providing a current liquidity buffer that supports operational flexibility without reliance on external financing. The company generates $593.2 million in operating cash flow, which significantly exceeds its capital expenditure of $102.4 million, indicating strong internal cash generation capabilities. This robust cash position underpins a low liquidity risk assessment, allowing the firm to fund growth initiatives and maintain financial stability without immediate refinancing pressures.

Profitability metrics reflect a mature but efficient business model, with a net income of $410.4 million on revenues of $4.03 billion, yielding a net margin of approximately 10.2%. The return on equity stands at 10.6%, while return on assets is 6.9%, suggesting effective utilization of its asset base. The gross profit of $2.71 billion indicates a gross margin of roughly 67.2%, consistent with high-value medical device manufacturers. While specific cohort median comparisons are not provided in the input data, the company’s ability to maintain positive operating income of $545.8 million amidst a competitive landscape demonstrates resilient pricing power and cost management. The valuation multiples, including a P/E of 27.93 and EV/EBITDA of 19.6, suggest the market prices in continued steady growth and high profitability expectations.

Revenue concentration and geographic exposure details are not explicitly broken down in the provided financial snapshot, limiting specific analysis of segment or regional risk. However, the company’s primary activity in health care equipment and supplies implies a diversified customer base across dental practices and orthodontic providers globally. The absence of detailed segment data prevents a granular assessment of revenue concentration risks, but the overall revenue scale of $4.03 billion suggests a broad market footprint. The company’s focus on digital healthcare solutions positions it within a growing segment of the health care industry, potentially mitigating risks associated with traditional product cycles.

Growth trajectory analysis is constrained by the absence of historical period data in the input. Without five-year annual or eight-quarter quarterly revenue and net income trends, it is not possible to quantify recent growth rates or identify inflection points in the company’s performance. The current financial snapshot provides a static view of profitability and liquidity but lacks the temporal depth required to assess momentum or deceleration. Analyst estimates, however, imply a positive outlook, with a mean price target of $210.75, suggesting expectations for continued revenue expansion and margin stability in the near term.

Risk assessment indicates low liquidity and dilution risks, with no immediate filing-based flags detected. The company’s zero debt profile eliminates interest rate risk and refinancing uncertainty, while the low dilution risk suggests that share count stability is maintained, with basic and diluted shares outstanding both at 71.36 million. The absence of key risk flags in the filing observations further supports a stable operational environment. However, the lack of detailed risk factor disclosures in the input limits a comprehensive evaluation of potential regulatory, competitive, or supply chain vulnerabilities.

Recent events include reconciler enqueue activities related to coverage closure and analysis job processing, which are internal system events rather than material business developments. Analyst sentiment remains positive, with a mean recommendation of 2.11 (on a scale where 1 is strong buy) and a median price target of $214.00, indicating confidence in the company’s future performance. The high price target of $240.00 and low of $175.00 reflect a range of expectations, but the overall consensus leans towards upside potential. No significant news events or transcript observations were provided that would alter the current risk or growth narrative.

Free cash flow surged 21.0% year-over-year to $450.9 million in fiscal 2025, demonstrating strong cash generation capabilities.

The company maintains a zero long-term debt position across all reported fiscal years, ensuring a pristine balance sheet.

Revenue growth remained positive at 0.9% year-over-year in fiscal 2025, reaching nearly $4 billion despite broader economic headwinds.

Liquidity and dilution risks are assessed as low, providing a stable financial foundation for continued operations and shareholder value.

Revenue growth has stagnated with a mere 0.5% compound annual growth rate over the past four years.

Gross profit decreased in fiscal 2026 to $2.75 billion, suggesting potential pricing pressure or rising cost of goods sold.

Revenue $1.04B, +6,2% YoY; Operating income +8,3% YoY.

• ▍Revenue $1.04B, +6,2% YoY
• ▍Operating income +8,3% YoY
• ▍Net income +21,0% YoY
• ▍Free cash flow +29,4% YoY
• ▍Net margin 10.8%

Revenue $1.05B, +5,3% YoY; Operating income +7,8% YoY.

• ▍Revenue $1.05B, +5,3% YoY
• ▍Operating income +7,8% YoY
• ▍Net income +30,8% YoY
• ▍Free cash flow +69,7% YoY
• ▍Net margin 13.0%

Revenue $995.7M, +1,8% YoY; Operating income −40,7% YoY.

• ▍Revenue $995.7M, +1,8% YoY
• ▍Operating income −40,7% YoY
• ▍Net income −51,1% YoY
• ▍Free cash flow −25,2% YoY
• ▍Net margin 5.7%

Revenue $1.01B, −1,6% YoY; Operating income +10,9% YoY.

• ▍Revenue $1.01B, −1,6% YoY
• ▍Operating income +10,9% YoY
• ▍Net income +29,0% YoY
• ▍Free cash flow +81,3% YoY
• ▍Net margin 12.3%

Revenue $979.3M; Operating income $131.1M.

• ▍Revenue $979.3M
• ▍Operating income $131.1M
• ▍Net margin 9.5%

Revenue $995.2M; Operating income $144.1M.

• ▍Revenue $995.2M
• ▍Operating income $144.1M
• ▍Net margin 10.4%

Revenue $977.9M; Operating income $162.3M.

• ▍Revenue $977.9M
• ▍Operating income $162.3M
• ▍Net margin 11.9%

Revenue $1.03B; Operating income $147.0M.

• ▍Revenue $1.03B
• ▍Operating income $147.0M
• ▍Net margin 9.4%

Revenue $4.03B, +0,9% YoY; Operating income −10,2% YoY.

• ▍Revenue $4.03B, +0,9% YoY
• ▍Operating income −10,2% YoY
• ▍Net income −2,6% YoY
• ▍Free cash flow +20,9% YoY
• ▍Net margin 10.2%

Revenue $4.00B, +3,5% YoY; Operating income −5,5% YoY.

• ▍Revenue $4.00B, +3,5% YoY
• ▍Operating income −5,5% YoY
• ▍Net income −5,3% YoY
• ▍Free cash flow +10,0% YoY
• ▍Net margin 10.5%

Revenue $3.86B, +3,4% YoY; Operating income +0,1% YoY.

• ▍Revenue $3.86B, +3,4% YoY
• ▍Operating income +0,1% YoY
• ▍Net income +23,1% YoY
• ▍Free cash flow +109,6% YoY
• ▍Net margin 11.5%

Revenue $3.73B, −5,5% YoY; Operating income −37,0% YoY.

• ▍Revenue $3.73B, −5,5% YoY
• ▍Operating income −37,0% YoY
• ▍Net income −53,2% YoY
• ▍Free cash flow −59,2% YoY
• ▍Net margin 9.7%